Xponential Fitness - XPOF Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $32.43
  • Forecasted Upside: 10.79%
  • Number of Analysts: 7
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 6 Buy Ratings
  • 1 Strong Buy Ratings
$29.27
▲ +0.35 (1.21%)

This chart shows the closing price for XPOF by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Xponential Fitness Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for XPOF and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for XPOF

Analyst Price Target is $32.43
▲ +10.79% Upside Potential
This price target is based on 7 analysts offering 12 month price targets for Xponential Fitness in the last 3 months. The average price target is $32.43, with a high forecast of $36.00 and a low forecast of $30.00. The average price target represents a 10.79% upside from the last price of $29.27.

This chart shows the closing price for XPOF for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 7 investment analysts is to buy stock in Xponential Fitness.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 1 strong buy ratings
  • 7 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/6/2021
  • 1 strong buy ratings
  • 8 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/4/2022
  • 1 strong buy ratings
  • 9 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/4/2022
  • 1 strong buy ratings
  • 9 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/3/2022
  • 1 strong buy ratings
  • 6 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/1/2022
  • 1 strong buy ratings
  • 5 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/30/2022
  • 1 strong buy ratings
  • 6 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/28/2023
  • 1 strong buy ratings
  • 6 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/30/2023

Latest Recommendations

  • 1 strong buy ratings
  • 6 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
3/13/2023GuggenheimBoost TargetBuy$29.00 ➝ $31.00Low
3/6/2023CitigroupBoost TargetBuy$31.00 ➝ $32.00Low
3/3/2023Morgan StanleyBoost TargetOverweight$28.00 ➝ $30.00Low
3/3/2023Raymond JamesBoost TargetStrong-Buy$30.00 ➝ $32.00Low
3/3/2023Robert W. BairdBoost Target$32.00 ➝ $34.00Low
2/15/2023CitigroupBoost TargetBuy$29.00 ➝ $31.00Low
1/31/2023Morgan StanleyBoost TargetOverweight$26.00 ➝ $28.00Low
1/13/2023B. RileyBoost TargetBuy$30.00 ➝ $32.00Low
1/10/2023Robert W. BairdBoost TargetOutperform$30.00 ➝ $32.00Low
12/6/2022CitigroupInitiated CoverageBuy$29.00Low
11/18/2022Robert W. BairdBoost Target$26.00 ➝ $30.00Low
11/16/2022GuggenheimBoost Target$26.00Low
11/11/2022Morgan StanleyBoost TargetOverweight$25.00 ➝ $26.00Low
11/11/2022Raymond JamesBoost TargetStrong-Buy$29.00 ➝ $30.00Low
11/11/2022B. RileyBoost TargetBuy$29.00 ➝ $30.00Low
11/11/2022Piper SandlerBoost TargetOverweight$34.00 ➝ $36.00Low
9/15/2022B. RileyInitiated CoverageBuy$29.00Low
8/12/2022Raymond JamesBoost TargetStrong-Buy$27.00 ➝ $29.00Low
3/14/2022Evercore ISIInitiated CoverageOutperform$34.00High
3/14/2022Robert W. BairdBoost Target$26.00 ➝ $28.00Low
3/7/2022Robert W. BairdBoost Target$26.00 ➝ $28.00High
3/4/2022Raymond JamesLower TargetStrong-Buy$28.00 ➝ $27.00High
11/16/2021Roth CapitalInitiated CoverageBuy$29.00Low
11/12/2021Raymond JamesBoost TargetStrong-Buy$14.00 ➝ $28.00High
11/12/2021Morgan StanleyBoost TargetOverweight$21.00 ➝ $23.00High
11/12/2021Robert W. BairdBoost TargetOutperform$16.00 ➝ $26.00High
11/12/2021Piper SandlerBoost TargetOverweight$20.00 ➝ $32.00High
10/15/2021Robert W. BairdReiterated RatingBuy$16.00High
9/28/2021Jefferies Financial GroupInitiated CoverageBuy$18.00High
9/22/2021Raymond JamesUpgradeMarket Perform ➝ Strong-Buy$14.00High
8/17/2021Bank of AmericaInitiated CoverageBuy$18.00High
8/17/2021Raymond JamesInitiated CoverageMarket PerformHigh
8/17/2021CitigroupInitiated CoverageBuy$14.50High
8/17/2021Jefferies Financial GroupInitiated CoverageBuy$18.00High
8/17/2021Robert W. BairdInitiated CoverageOutperform$16.00High
8/17/2021Morgan StanleyInitiated CoverageOverweight$17.00High
8/17/2021Piper SandlerInitiated CoverageOverweight$20.00High
8/17/2021GuggenheimInitiated CoverageBuyHigh
(Data available from 3/30/2018 forward)

News Sentiment Rating

1.23 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 12 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/1/2022
  • 4 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/1/2022
  • 9 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/31/2022
  • 16 very positive mentions
  • 3 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
11/30/2022
  • 3 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/30/2022
  • 8 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/29/2023
  • 15 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
2/28/2023
  • 12 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/30/2023

Current Sentiment

  • 12 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.
Xponential Fitness logo
Xponential Fitness, Inc., through its subsidiaries, operates as a boutique fitness franchisor in the United States and internationally. The company offers fitness and wellness services, including pilates, barre, cycling, stretching, rowing, yoga, boxing, dancing, running, and functional training under the Club Pilates, Pure Barre, CycleBar, StretchLab, Row House, YogaSix, Rumble, AKT, Stride, and BFT brands. As of December 31, 2021, it had 1,556 franchisees operating 1,954 open studios on an adjusted basis. The company was founded in 2017 and is headquartered in Irvine, California.
Read More

Today's Range

Now: $29.27
Low: $28.94
High: $29.73

50 Day Range

MA: $26.70
Low: $23.76
High: $30.49

52 Week Range

Now: $29.27
Low: $11.20
High: $30.70

Volume

438,949 shs

Average Volume

552,032 shs

Market Capitalization

$1.44 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.41

Frequently Asked Questions

What sell-side analysts currently cover shares of Xponential Fitness?

The following equities research analysts have issued research reports on Xponential Fitness in the last year: B. Riley, Citigroup Inc., Guggenheim, Morgan Stanley, Piper Sandler, Raymond James, and Robert W. Baird.
View the latest analyst ratings for XPOF.

What is the current price target for Xponential Fitness?

7 Wall Street analysts have set twelve-month price targets for Xponential Fitness in the last year. Their average twelve-month price target is $32.43, suggesting a possible upside of 10.8%. Piper Sandler has the highest price target set, predicting XPOF will reach $36.00 in the next twelve months. Morgan Stanley has the lowest price target set, forecasting a price of $30.00 for Xponential Fitness in the next year.
View the latest price targets for XPOF.

What is the current consensus analyst rating for Xponential Fitness?

Xponential Fitness currently has 6 buy ratings and 1 strong buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe XPOF will outperform the market and that investors should add to their positions of Xponential Fitness.
View the latest ratings for XPOF.

What other companies compete with Xponential Fitness?

How do I contact Xponential Fitness' investor relations team?

The company's listed phone number is 949-346-3000 and its investor relations email address is [email protected] The official website for Xponential Fitness is www.xponential.com. Learn More about contacing Xponential Fitness investor relations.